ABBV vs. PLTR: AbbVie vs. Palantir Stock Comparison

November 11, 2026

How do AbbVie (ABBV) and Palantir (PLTR) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

AbbVie (ABBV) is classified in the Health Care sector (Pharmaceuticals, Biotechnology & Life Sciences), whereas Palantir (PLTR) belongs to Information Technology (Software & Services) — their GICS classifications point to very different parts of the market.

Company profile comparison for AbbVie (ABBV) and Palantir (PLTR)
Profile Item	ABBV	PLTR
Name	AbbVie Inc.	Palantir Technologies Inc. Class A Common Stock
Country/Region	United States	United States
GICS Sector	Health Care	Information Technology
GICS Industry Group	Pharmaceuticals, Biotechnology & Life Sciences	Software & Services
GICS Industry	Biotechnology	Software
GICS Sub-Industry	Biotechnology	Application Software
Market Capitalization	514.92 billion USD	386.44 billion USD
Currency	USD	USD
Exchange	NYSE	Nasdaq
Listing Date	January 2, 2013	September 30, 2020
Security Type	Common Stock	Common Stock

Price Performance

Cumulative Growth

ABBV

PLTR

GSPC

AbbVie (ABBV) vs. Palantir (PLTR), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…

Trailing total returns for AbbVie (ABBV) and Palantir (PLTR). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…

Calendar-year total returns for AbbVie (ABBV) and Palantir (PLTR). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for AbbVie (ABBV) and Palantir (PLTR)
Metric	ABBV	PLTR
Total Return (1Y)	37.33%	-4.94%
Total Return (3Y, Annualized)	32.74%	109.97%
Total Return (5Y, Annualized)	24.73%	47.47%

Risk Profile

Drawdown History

ABBV

PLTR

GSPC

AbbVie (ABBV) vs. Palantir (PLTR), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…

Distribution of monthly total returns for AbbVie (ABBV) and Palantir (PLTR). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Palantir (PLTR) has an aggressive beta of 1.63, indicating higher sensitivity to broad-market moves, while AbbVie (ABBV) is defensive at 0.21 and tends to be less market-sensitive — they sit on opposite ends of the beta spectrum.

Risk profile metrics for AbbVie (ABBV) and Palantir (PLTR)
Metric	ABBV	PLTR
Volatility (1Y, Annualized)	25.65%	60.50%
Beta (5Y)	0.21	1.63
Max Drawdown (5Y)	-21.92%	-75.26%
Avg. Volume (3M)	4.76M	27.20M

Risk-Adjusted Performance

Risk-Return Positioning

ABBV and PLTR are plotted by 1-year volatility (risk) and 1-year return. Each dashed Capital Allocation Line uses that stock's own industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for AbbVie (ABBV) and Palantir (PLTR)
Metric	ABBV	PLTR
Sharpe Ratio (1Y)	1.29	-0.15
Sortino Ratio (1Y)	2.02	-0.24

Profitability

ROE (TTM)

Capital efficiency shows on one side only: Palantir (PLTR) earns 40.91% on shareholders’ equity, ranked against its industry; AbbVie (ABBV) has no ROE this period.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

Max: 109.18%
Q3: 6.23%
Median: -26.66%
Q1: -64.05%
Min: -167.77%
ABBV: --

PLTR

Software & Services industry group

40.91%

Max: 53.85%
PLTR: 40.91%
Q3: 17.90%
Median: 6.59%
Q1: -9.59%
Min: -50.52%

AbbVie (ABBV) vs. Palantir (PLTR): ABBV does not report ROE, so it has no value marker; PLTR is benchmarked against the Software & Services industry group.

Net Margin (TTM)

Palantir (PLTR) at 50.34% keeps the most of each sales dollar — above its industry’s net margin range — and AbbVie (ABBV) at 15.67% also retains a top-quartile share.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

15.67%

Max: 18.05%
ABBV: 15.67%
Q3: 4.78%
Median: 0.00%
Q1: -4.14%
Min: -17.05%

PLTR

Software & Services industry group

50.34%

PLTR: 50.34%
Max: 41.17%
Q3: 15.28%
Median: 4.63%
Q1: -5.42%
Min: -33.17%

AbbVie (ABBV) vs. Palantir (PLTR): A comparison of their net margin against their respective Pharmaceuticals, Biotechnology & Life Sciences and Software & Services industry group benchmarks.

Operating Margin (TTM)

Both AbbVie (ABBV) at 39.59% and Palantir (PLTR) at 46.89% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

39.59%

Max: 83.12%
ABBV: 39.59%
Q3: 14.77%
Median: 0.00%
Q1: -78.82%
Min: -207.40%

PLTR

Software & Services industry group

46.89%

PLTR: 46.89%
Max: 46.89%
Q3: 17.64%
Median: 8.73%
Q1: -2.13%
Min: -30.45%

AbbVie (ABBV) vs. Palantir (PLTR): A comparison of their operating margin against their respective Pharmaceuticals, Biotechnology & Life Sciences and Software & Services industry group benchmarks.

Profitability Metrics

Profitability metrics for AbbVie (ABBV) and Palantir (PLTR)
Metric	ABBV	PLTR
ROE (TTM)	--	40.91%
ROA (TTM)	10.74%	19.31%
Net Margin (TTM)	15.67%	50.34%
Operating Margin (TTM)	39.59%	46.89%
Gross Margin (TTM)	73.72%	84.74%

Growth

Revenue Growth

Palantir (PLTR) at 56.18% clears its industry range for revenue growth, far stronger top-line momentum than AbbVie (ABBV) at 8.57%, which is closer to a typical peer reading.

AbbVie (ABBV) vs. Palantir (PLTR): A comparison of their Revenue Growth across different time periods.

EPS Growth

Palantir (PLTR) at 231.06% clears its industry range for EPS growth, a much stronger earnings trajectory than AbbVie (ABBV) at -0.84%, which is closer to a typical peer reading.

AbbVie (ABBV) vs. Palantir (PLTR): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for AbbVie (ABBV) and Palantir (PLTR)
Metric	ABBV	PLTR
Revenue Growth (YoY)	8.57%	56.18%
Revenue Growth (3Y CAGR)	1.75%	32.92%
EPS Growth (YoY)	-0.84%	231.06%
EPS Growth (3Y CAGR)	-29.03%	--

Financial Strength

Current Ratio (MRQ)

Palantir (PLTR) at 7.10 carries current ratio above its industry’s typical mid-range, while AbbVie (ABBV) at 0.87 runs in the tighter-liquidity quartile — different working-capital profiles, both worth examining.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.87

Max: 25.13
Q3: 12.13
Median: 5.52
Q1: 2.47
ABBV: 0.87
Min: 0.10

PLTR

Software & Services industry group

7.10

PLTR: 7.10
Max: 5.11
Q3: 2.77
Median: 1.67
Q1: 1.01
Min: 0.03

AbbVie (ABBV) vs. Palantir (PLTR): A comparison of their current ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Software & Services industry group benchmarks.

Debt / Equity (MRQ)

Only one side’s leverage can be read here: Palantir (PLTR) carries debt-to-equity ratio of 0.02 against its industry range, while AbbVie (ABBV) reports no figure this period.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

Max: 1.42
Q3: 0.65
Median: 0.15
Q1: 0.02
Min: 0.00
ABBV: --

PLTR

Software & Services industry group

0.02

Max: 2.52
Q3: 1.13
Median: 0.40
Q1: 0.07
PLTR: 0.02
Min: 0.00

AbbVie (ABBV) vs. Palantir (PLTR): ABBV does not report debt-to-equity ratio, so it has no value marker; PLTR is benchmarked against the Software & Services industry group.

Financial Strength Metrics

Financial strength metrics for AbbVie (ABBV) and Palantir (PLTR)
Metric	ABBV	PLTR
Current Ratio (MRQ)	0.87	7.10
Debt / Equity (MRQ)	--	0.02
Net Debt / EBITDA	2.21	-3.08

Dividends

Dividend Yield (TTM)

Palantir (PLTR) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile AbbVie (ABBV) reports a yield of 2.40%, ranking against industry peers normally.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.40%

ABBV: 2.40%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

PLTR

Software & Services industry group

0.00%

PLTR: 0.00%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

AbbVie (ABBV) vs. Palantir (PLTR): A comparison of their dividend yield against their respective Pharmaceuticals, Biotechnology & Life Sciences and Software & Services industry group benchmarks.

Dividend Payout Ratio (TTM)

AbbVie (ABBV) reports payout ratio above 100% at 117.35%, meaning dividends exceeded current-period earnings; Palantir (PLTR) pays no dividend (payout 0.00%).

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

117.35%

ABBV: 117.35%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

PLTR

Software & Services industry group

0.00%

PLTR: 0.00%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

AbbVie (ABBV) vs. Palantir (PLTR): A comparison of their payout ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Software & Services industry group benchmarks.

Dividend Metrics

Dividend metrics for AbbVie (ABBV) and Palantir (PLTR)
Metric	ABBV	PLTR
Dividend Yield (TTM)	2.40%	0.00%
Dividend Payout Ratio (TTM)	117.35%	0.00%

Valuation

P/E Ratio (TTM)

Both AbbVie (ABBV) at 50.05 and Palantir (PLTR) at 112.94 sit in the richer earnings-multiple quartile for P/E ratio, so investors are paying more for TTM earnings than they pay for typical peers.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

50.05

Max: 85.34
ABBV: 50.05
Q3: 43.46
Median: 26.69
Q1: 13.30
Min: 0.07

PLTR

Software & Services industry group

112.94

PLTR: 112.94
Max: 112.94
Q3: 60.32
Median: 32.91
Q1: 18.77
Min: 6.69

AbbVie (ABBV) vs. Palantir (PLTR): A comparison of their P/E ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Software & Services industry group benchmarks.

P/S Ratio (TTM)

AbbVie (ABBV) at 7.80 prices around its industry’s typical P/S ratio, while Palantir (PLTR) at 53.02 clears its benchmark range — PLTR looks notably rich on sales.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

7.80

Max: 58.18
Q3: 25.77
ABBV: 7.80
Median: 7.30
Q1: 3.01
Min: 0.01

PLTR

Software & Services industry group

53.02

PLTR: 53.02
Max: 17.91
Q3: 8.78
Median: 4.25
Q1: 2.23
Min: 0.02

AbbVie (ABBV) vs. Palantir (PLTR): A comparison of their P/S ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Software & Services industry group benchmarks.

P/B Ratio (MRQ)

AbbVie (ABBV) reports a negative P/B ratio of -112.34, meaning negative book equity — the multiple itself is not meaningful for valuation. Meanwhile Palantir (PLTR) reports 34.41, ranking against industry peers normally.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

-112.34

Max: 13.53
Q3: 6.54
Median: 3.25
Q1: 1.69
Min: -5.59
ABBV: -112.34

PLTR

Software & Services industry group

34.41

PLTR: 34.41
Max: 16.63
Q3: 8.50
Median: 4.30
Q1: 1.92
Min: -3.90

AbbVie (ABBV) vs. Palantir (PLTR): A comparison of their P/B ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Software & Services industry group benchmarks.

Valuation Metrics

Valuation metrics for AbbVie (ABBV) and Palantir (PLTR)
Metric	ABBV	PLTR
P/E Ratio (TTM)	50.05	112.94
P/S Ratio (TTM)	7.80	53.02
P/B Ratio (MRQ)	-112.34	34.41
Free Cash Flow Yield (TTM)	3.44%	0.69%